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ElectrophysiologyFree fatty acids (FFAs) are non-competitive antagonists of the nicotinic acetylcholine receptor (AChR). Their
site of action is supposedly located at the lipid-AChR interface. To elucidate the mechanism involved in this
antagonism, we studied the effect that FFAs with a single double-bond at different positions (ω6, ω9, ω11
and ω13 cis-18:1) have on different AChR properties. Electrophysiological studies showed that only two
FFAs (ω6 and ω9) reduced the duration of the channel open-state. The briefest component of the closed-
time distribution remained unaltered, suggesting that ω6 and ω9 behave as allosteric blockers. Fluorescence
resonance energy transfer studies indicated that all FFAs locate at the lipid-AChR interface, ω6 being restrict-
ed to annular sites and all others occupying non-annular sites. The perturbation of the native membrane
order by FFAs was evaluated by DPH (1,6-diphenyl-1,3,5-hexatriene) and Laurdan ﬂuorescence polarization
studies, with the greatest decrease observed forω9 andω11. AChR conformational changes produced by FFAs
present at the lipid bilayer were evaluated by ﬂuorescence quenching studies of pyrene-labeled AChR and
also using the AChR conformational-sensitive probe crystal violet. All cis-FFAs produced AChR conformational
changes at the transmembrane level, but only ω9, ω11 and ω13 perturbed the resting state. Thus, the posi-
tion and isomerism of the torsion angle of unsaturated FFAs are probably a key factor in terms of AChR block-
age, suggesting that FFAs with a unique cis double bond at a superﬁcial position inside the membrane directly
inhibit AChR function by perturbing a potential conserved core structure for AChR gating at that level.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The nicotinic acetylcholine receptor (AChR) is an integralmembrane
protein embedded in the postsynaptic membrane and composed of ﬁve
homologous subunits organized around a central pore [1]. All subunits
consist of an amino-terminal extracellular domain followed by four
transmembrane (TM) hydrophobic domains 20–30 amino acids long
(M1 through M4) connected to one another by loops of varying length,
and ending with a very short extracellular carboxyl terminus [2]. The
AChR TM domain is arranged in three concentric rings: the M2 TMetylcholine receptor; Carb, car-
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rights reserved.segments of each subunit form the inner ring, constituting the ion chan-
nel itself; the M1 and M3 TM-segments make up the middle ring, and
the M4 TM-segments form the outer ring, which is the TM-segment
closest to the lipid microenvironment [3,4]. ESR studies have identiﬁed
differences between the signals proceeding from bulkmembrane lipids
and those from the protein-immobilized lipid that surrounds the AChR
in native and reconstituted membranes [5,6]. Thus, it is possible to dis-
tinguish an annular lipid layer surrounding the AChR [5] and non-
annular lipids inserted between the different TM domains of the pro-
tein. These two types of lipid environments have distinct compositions
and hence different biophysical properties [7].
The AChR is an allosteric protein, switching between open and
closed states. Ligand binding regulates the conformational paths of
AChR opening and desensitization, possibly through several interme-
diate states [8]. The AChR has two closed stable functional states –
the resting state (R) in the absence of agonist and the slow-onset
desensitized state (D) in the presence of agonist– and two metastable
functional states: a fast-onset desensitized state and an open state
[9,10]. Previous studies using reconstituted membranes have found
that the proportion of receptors in the R and D states appears to de-
pend on the ﬁnal lipid composition, regardless of the presence or ab-
sence of agonist [11], leading to the conclusion that modulation of
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neither the R nor the D state, but adopts a novel conformation where-
by the allosteric coupling between the neurotransmitter-binding sites
and the TMpore is lost. Previous studies from our laboratory and other
authors have suggested that the M4 TM helix acts as a lipid-sensor,
linking bilayer properties to AChR function [12–14].
Free fatty acids (FFAs) have been found to inhibit the AChR in a
noncompetitive manner [4,8–15]. Minota and Watanabe suggested
that this inhibition by FFAs may occur through their action on alloste-
ric sites of the AChR [16]. Among all lipids tested, FFAs were the ones
with the highest afﬁnity for the native membrane-bound AChR, at
the AChR-lipid interface [7,17]. One of the preferred targets of FFAs ap-
pears to be the non-annular boundary lipid-AChR domain [13,18,19],
although FFAs also bind to other classes of sites. Recently, we demon-
strated that FFAs modulate AChR function by a mechanism of action
different from that used by other hydrophobic inhibitors of the
AChR, such as steroids [14]. The direct contact between exogenous
FFAs and the AChR TM segments might remove the AChR from its R
state, causing its functional inhibition. We also postulated a possible
relationship between the membrane physical state and the AChR con-
formational state, whichwould explain why the AChR activation equi-
librium is affected by changes in the lipid microenvironment [14].
In the present work we focused our attention on the effect of cis-
monounsaturated FFAs with the double bond at different positions
along the hydrocarbon chain on AChR function, also looking at the
protein–lipid interface in native Torpedo californica membranes. Func-
tionality was studied using the patch-clamp technique in the cell-
attached conﬁguration in the presence or absence of FFAs. In an attempt
to understand the effect of these FFAs on the modulation of AChR con-
formation, we used the ﬂuorescent dye crystal violet (CrV), which has
higher afﬁnity for the D state than for the R state of AChR, and
quenching experiments of a pyrene-labeled AChR reconstituted in a
model system. Membrane order perturbations by FFA addition were
followed with the ﬂuorescence probes DPH and Laurdan. Laurdan mol-
ecules were also used to study FFA location at both annular and non-
annular sites. Only two cis-unsaturated FFAs inhibit and generate con-
formational changes in the AChR whereas most of the FFAs modiﬁed
the AChR conformational state and biophysical properties of the mem-
brane. Furthermore, not all FFAs locate at the same sites at the lipid-
AChR interface.
2. Materials and methods
2.1. Materials
T. californica specimens obtained from the Paciﬁc coast of California
(Aquatic Research Consulants, San Pedro, CA) were killed by pithing,
and the electric organs were dissected and stored at −70 °C until
use. Laurdan and pyrene-maleimides were purchased from Molecular
Probes (Eugene, OR). Afﬁ-Gel® 10 Gel and dithiothreitol were obtained
from Bio-Rad. Synthetic lipids and 5-spin labeled fatty acid (5-SLFA)
were from Avanti Polar Lipids, Inc. (Birmingham, AL). Crystal violet
(CrV) and all other drugs were obtained from Sigma-Aldrich.
2.2. Methods
2.2.1. Preparation of AChR-rich membranes
AChR-rich membrane fragments were prepared from T. californica
electric tissue as described previously [20]. Brieﬂy, electric tissue was
chopped into small pieces, homogenized using a Virtis homogenizer
under controlled conditions, and submitted to a series of centrifuga-
tion steps ending in a high-speed sucrose gradient centrifugation.
The obtained middle fraction corresponds to AChR-rich membranes
with a speciﬁc activity of the order of 1.0–1.5 nmol of α-bungarotoxin
sites/mg of protein [20]. The orientation of AChR in the membrane
vesicles was determined by comparing the toxin binding sites in thepresence and in the absence of Triton X-100 as described by Hartig
and Raftery [21,22].
2.2.2. Afﬁnity column preparation and AChR puriﬁcation
T. californica crude membranes were solubilized in 1% sodium cho-
late (2 mg/ml protein concentration) for 45 min at 4 °C and then cen-
trifuged at 74,000×g for 1 h to discard the insoluble material. The
AChR was puriﬁed by afﬁnity chromatography in the presence of syn-
thetic lipids [23,24]. Brieﬂy, the afﬁnity column was prepared by cou-
pling cystamine to Afﬁ-Gel 10, reduction with dithiothreitol, and ﬁnal
modiﬁcation with bromoacetylcholine bromide. The supernatant was
applied to the afﬁnity column. To facilitate complete exchange of en-
dogenous for deﬁned lipids, the columnwas thenwashedwith a linear
gradient of deﬁned lipids (POPC:POPA:Chol 3:1:1) dissolved in dialy-
sis buffer (100 mM NaCl, 0.1 mM phosphate, 0.1 mM EDTA, 0.02%
NaN3, pH 7.8) containing 1% cholate, from 1.3 to 3.2 mM and then to
0.13 mM lipid concentration [23]. The AChR was then eluted from
the column with a 0.13 mM lipid solution in 250 mM NaCl, 0.1 mM
EDTA, 0.02% NaN3, 5 mM phosphate, pH 7.8, with 0.5% cholate and
10 mM carbamylcholine (Carb). After elution from the column, the
AChR was dialyzed against 1 l of dialysis buffer with ﬁve buffer
changes (every 12 h) at 4 °C. AChR purity was checked by SDS-PAGE,
and protein concentration was determined by the method of Lowry
[25]. The samples were stored at−70 °C until use.
2.2.3. N-(1-pyrenyl)maleimide AChR labeling
The labeling of TM AChR cysteines was performed according to Li
et al. [26] and Narayanaswami et al. [27,28] with slight modiﬁcations
as described in Fernández Nievas et al. [14]. Brieﬂy, puriﬁed AChR
solubilized in 1% cholate (1 mg/ml) was incubated in the presence of
1 mM N-PyrM for 1 h at room temperature with gentle shaking. The
solution was centrifuged at 70,000×g for 45 min to pellet aggregates.
The supernatant was dialyzed against 1 l of dialysis buffer with ﬁve
buffer changes (every 12 h) at 4 °C and stored at −20 °C until use.
N-PyrM-AChR samples were submitted to SDS-PAGE, and the N-
PyrM label was visualized under a UV transilluminator showing that
the band corresponding to the γ subunit was predominantly labeled.
2.2.4. Preparation of free fatty acid solutions and titration of membrane
fragments
Petroselenic acid (cis-18:1ω-6), oleic acid (cis-18:1ω-9), vaccenic
acid (cis-18:1ω-11), cis-13-octadecenoic acid (cis-18:1ω-13) and elaidic
acid (trans-18:1ω-9) were dissolved in ethanol. After each FFA addition,
samples were kept at 25 °C for 45 min to allow equilibration of the FFA
with the membrane. In all cases the amount of ethanol added to the
samples was kept below 0.5%.
2.2.5. Cell culture
CHO-K1/A5 cells stably expressing adult muscle AChR [29] were
cultured in Ham F12 medium supplemented with 10% bovine fetal
serum and 40 mg/ml of the selection antibiotic G418 (Sigma) in the
cell medium.
2.2.6. Single-channel recordings
Single-channel currents were recorded in the cell-attached conﬁg-
uration [30] at a membrane potential of −70 mV and 20 °C using an
Axopatch 200B patch-clamp ampliﬁer (Axon Instruments, Inc., Foster
City, CA), digitized at 94 kHz with an ITC-16 interface (Instrutech Cor-
poration, Long Island, New York, NY) and transferred to a computer
using the program Acquire (Bruxton Corporation, Seattle, WA). The
bath and pipette solutions contained 142 mM KCl, 5.4 mM NaCl,
1.8 mM CaCl2, 1.7 mM MgCl2 and 10 mM N-2-hydroxyl piperazine-
N0-2-ethane sulfonic acid, pH 7.4. Patch pipettes were pulled from
Kimax-51 capillary tubes (Kimble Products, Vineland, New Jersey,
USA), coated with Coat D (M-Line accessories, Measurements Group,
Raleigh, NC) and ﬁre-polished. Pipette resistances ranged from 5 to
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solution. FFAs (cis-18:1ω-6; cis-18:1ω-9; trans-18:1ω-9; cis-18:1ω-
11 and cis-18:1ω-13) were prepared from a 20 mM stock solution
and stored at −20οC. The FFA was dissolved in the cell medium
(60 μM) for 30 min at 37 °C prior to each experiment to allow equili-
bration of the FFAwith the cell membrane. Mediumwas then replaced
with bath solution and 1 μM ACh was applied to the cell from the pi-
pette tip. Detection of single-channel events using the program TAC
(Bruxton Corp.) followed the half-amplitude threshold criterion at a
bandwidth of 5 kHz. Open, burst and closed-time histograms were
plotted using a logarithmic abscissa and square-root ordinate and
ﬁtted to the sum of exponential functions by the maximum likelihood
criterion using the program TACFit (Bruxton Corp.). Burst resolution
was obtained from the delay between the main closed-time compo-
nent and the succeeding one. Data are expressed as mean±S.D.
from independent experiments. Statistical analysis was performed
using Student's t-test.
2.2.7. Fluorescence measurements
AChR-rich membranes and N-PyrM-AChR were suspended in buffer
A (150 mMNaCl, 0.25 mMMgCl2, and 20mMHEPES buffer, pH 7.4) at a
ﬁnal concentration of 50–100 μg of protein/ml (0.2–0.4 μM) or 20 μg/ml,
respectively. The optical density of the membrane suspension was kept
below 0.1 to minimize light scattering. All ﬂuorimetric measurements
were performed in an SLM model 4800 ﬂuorimeter (SLM Instruments,
Urbana, IL) using a vertically polarized light beam from Hannovia
200-W mercury/xenon arc obtained with a Glan-Thompson polarizer
(4-nmexcitation and emission slits) and 2-ml quartz cuvettes. The tem-
perature was set at 25 °C with a thermostated circulating water bath
(Haake, Darmstadt, Germany).
2.2.8. Generalized polarization (GP) determination
Laurdan was added to AChR-rich membrane samples (50 μg
protein/ml) from an ethanol solution to give a ﬁnal probe concentra-
tion of 0.6 μM. The amount of organic solvent was kept below 0.2%.
The samples were incubated for 45 min before the addition of increas-
ing concentrations of the different FFAs. Each addition was followed
by a further 45-min incubation to allow equilibration, and then the
emission spectra were collected. GP values were obtained from emis-
sion spectra using an excitation wavelength of 290 nm or 360 nm, for
Förster-type resonance energy transfer (FRET) or direct excitation, re-
spectively, as follows
GP ¼ I434−I490ð Þ= I434 þ I490ð Þ
where I434 and I490 are the emission intensities at the characteristic
wavelength of the gel and liquid-crystalline phases, respectively [31,32].
2.2.9. Anisotropy measurements
AChR-rich membranes (50 μg protein/ml) reconstituted in buffer
A were incubated with the ﬂuorescence probe 1,6-diphenyl-1,3,5-
hexatriene (DPH) (0.6 μM ﬁnal concentration) for 45 min, followed
by the addition of increasing concentrations of the FFAs. The samples
were incubated again for 45 min before anisotropy (r) measurements.
The excitation and emission wavelengths used were 365 and 425 nm,
respectively. Fluorescence anisotropy measurements were done in
the T format with Schott KV418 ﬁlters in the emission channels and
corrected for optical inaccuracies and background signals. The anisot-
ropy value, r, was obtained according to the following equation [33]:
r ¼ Iv=Ihð Þv− Iv=Ihð Þh
 Þ= Iv=Ihð Þv þ Iv=Ihð Þh
 
where (Iv/Ih)v and (Iv/Ih)h are the ratios of the emitted vertical or hor-
izontally polarized light to the exciting, vertical or horizontally polar-
ized light, respectively. The r value can range between−0.2 and 0.4,
higher values denoting higher structural lipid order [34].2.2.10. Förster resonance energy transfer (FRET) measurements
The energy transfer efﬁciency (E) in relation to all other deactiva-
tion processes of the excited donor depends on the sixth power of the
distance between donor and acceptor. According to Förster's theory
[35] E can be calculated as follows:
E ¼ 1– I=I0ð Þ
where I and I0 are the emission intensities in the presence and in the
absence of the acceptor, respectively. Here, I corresponds to the max-
imal intrinsic protein emission intensity, which is 330 nm. The excita-
tion wavelength was set at 290 nm.
T. californica AChR-rich membranes (50 μg protein/ml) were incu-
bated with the ﬂuorescence probe Laurdan for 45 min. Initial ﬂuores-
cence measurements were taken before the addition of the Laurdan
probe. Increasing concentrations of the FFAswere then added, followed
by a 45-min incubation before taking the ﬂuorescence emission spectra.
For each condition, the normalized FRET efﬁciency was calculated as
follows:
Enor ¼ I−Ilau
 
= I0–I0
lau
 
where I0lau and I0 values are the initial emission intensities of the sam-
ples with or without Laurdan for any given condition, respectively.
2.2.11. CrV ﬂuorescent measurements
CrV experimentswere conducted as described previously [14]. AChR-
rich membranes were suspended in buffer A (100 μg of protein/ml) and
incubated with FFAs for 45 min. For measurements conducted with the
AChR in the desensitized state, T. californicamembranes were incubated
with 0.5 mM Carb for 15 min following the FFA addition. The mem-
branes were subsequently titrated with increasing concentrations of
CrV (in buffer A). After each addition of CrV the samples were incubated
for 15 min before obtaining the ﬂuorescence emission spectra. CrV was
excited at 600 nm, and the ﬂuorescence emission spectra were collected
from 605 to 700 nm. Before the ﬁrst addition of CrV, a background ﬂuo-
rescence emission spectrum was obtained for each sample. The spec-
trum was then subtracted from the emission spectra obtained in the
presence of CrV and the maximum intensity (at 623–625 nm) was mea-
sured. To determine the CrV dissociation constants (KD), the value of the
CrV maximum ﬂuorescence emission was plotted as a function of the
logarithmic CrV concentration (M). The resulting sigmoid curve was
ﬁtted to the Boltzmann function and the KD was calculated.
2.2.12. Fluorescence quenching with a spin-label FFA
Quenching experiments were done using N-PyrM AChR. The excita-
tion wavelength was 345 nm and the maximum pyrene ﬂuorescence
emission was recorded at 373 nm. N-PyrM-AChR samples (20 μg/ml)
were incubated with the different FFAs (60 μM). Samples with or with-
out FFA were then titrated with increasing concentrations of 5-SLFA or
with vehicle (ethanol) only and incubated for 30 min at 25 °C prior to
the ﬂuorescence measurement in order to let the 5-SLFA reach equilib-
rium with the sample. From the ﬂuorescence data, Stern–Volmer plots
were obtained according to the equation:
F0=F ¼ 1þ Ksv Q½ 
where F0 and F correspond to the ﬂuorescence emission of N-PyrM-
AChR in the absence and presence of 5-SLFA, respectively, [Q] is the
concentration of the quencher, and Ksv is the Stern–Volmer constant
[36], a measure of the quencher concentration in the vicinity of the
ﬂuorophore.
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Fig. 2. Changes in normalized FRET efﬁciency (E) between intrinsic ﬂuorescence in na-
tive T. californica AChR-rich membrane and Laurdan upon addition of increasing con-
centrations of cis-18:1ω-6 (○), cis-18:1ω-9 (□), cis-18:1ω-11 (♦) and cis-18:1ω-13
(▾). The E values obtained in the presence of FFAs were normalized with respect to
the corresponding E value in its absence (100%). Each point corresponds to the aver-
age±S.D. of more than four independent experiments. Statistically signiﬁcant differ-
ences (*, pb0.05 and **, pb0.01) compared with the control values.
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We used a variety of mono-unsaturated FFAs (cis-18:1ω-6, cis-
18:1ω-9, cis-18:1ω-11, cis-18:1ω-13, and trans-18:1ω-9) to study
the possible relationship between the position of the double bond
and the perturbation of AChR function, AChR conformation and mem-
brane ﬂuidity. Fig. 1 shows representative chemical structures of the
ﬁve different FFAs tested. The gradual displacement of the kink with
the variation in the position of the single double bond of the FFAs
and the wide divergence between the broken chain of the cis-
unsaturated FFAs and the linear chain of the trans-unsaturated FFAs
become apparent.
3.1. FFA location at the lipid-AChR interface
To determine whether the different FFAs studied were bound either
to annular lipid sites or non-annular lipid sites or both, FRET studies
were performed between the intrinsic ﬂuorescence of Torpedo AChR
as donor and Laurdan probe as acceptor. FRET efﬁciency between this
acceptor–donor pair was introduced by our group [37] and subsequent-
ly used to disclose different phospholipid (PC) and cholesterol sites on
the AChR surface [19]. It was observed that both types of lipids elicited
displacements of the ﬂuorescent probe and that such displacements
were not only independent of one another but also additive, and that
Laurdan displacement elicited by FFAs alone amounted to the sum of
the effects caused by PC and cholesterol together. It was thus possible
to distinguish PC sites from cholesterol sites, both of which are accessi-
ble to FFAs. Furthermore, considering that PC and cholesterol are typical
examples of annular and non-annular lipids, respectively, we argued
that a) if Laurdan can sense different types of sites at the lipid–protein
interface, Laurdan is expected to be located at these sites; and b) the
two different sites shown by Laurdan may correspond to annular and
non-annular sites, as originally postulated by Jones and McNamee [18]
and Narayanaswami and McNamee [27] following a different method-
ology (AChR covalently labeled with N-(1-pyrenyl)maleimide and bro-
minated lipids as quenchers). Recent studies from our group showed
that the proﬁle of the curves obtained with normalized FRET efﬁciency
(ΔE) values as a function of the concentration of an exogenous hydro-
phobic molecule is related to their binding to distinct sites at the
AChR-lipid interface. This is due to the displacement of acceptor mole-
cules (Laurdan) from the AChR microenvironment by the addition of
an exogenous molecule. We therefore proposed that the decrease in E
could be dissected into two characteristically different regions [13].
The steep initial slope is a consequence of the higher afﬁnity of exoge-
nous lipids to annular sites which provoke the displacement of Laurdan
from them [38]. The second slope, a linear decrease in E, is related to an-
nular sites, implying Laurdan displacement by exogenous lipids which
are rapidly exchanged with the rest of the membrane lipids.
Here, AChR-richmembranes previously labeledwith Laurdanwere ti-
tratedwith thedifferent FFAs and theﬂuorescencemeasurements carried
out. As Fig. 2 shows, the presence of most of the cis-monounsaturated
acids (cis-18:1ω-9, cis-18:1ω-11 and cis-18:1ω-13) inside themembrane
caused a signiﬁcant diminution in the normalized ΔE –more than a 50%vaccenic a
(cis-18:1ω
petroselenic acid 
(cis-18:1 ω6)
oleic acid 
(cis-18:1 ω9)
Fig. 1.Molecular structures of the FFAs studied in this work. The break line shows the positidecrease with respect to control values. Only cis-18:1ω-6 induced a
small decrease in ΔE values (less than 15% diminution compared to con-
trol values). Comparing the present results with those of previous work
[13], we can infer that the proﬁle of diminution of the normalized ΔE,
caused by the presence of cis-18:1 ω-6 in the membrane is caused by
the location of this FFA only in annular sites, whereas the rest of the cis-
FFAs (cis-18:1ω-9, cis-18:1ω-11 and cis-18:1ω-13) locate both in annular
and non-annular sites.
3.2. Inhibition of the AChR by FFA
Previous results from our laboratory using the patch-clamp tech-
nique in the cell-attached conﬁguration demonstrated that cis-18:1ω-9
behaves as an AChR inhibitor [39]. Here, similar studies were performed
in order to evaluate the effect of other monounsaturated FFAs on AChR
single-channel kinetics. Control recordings obtained in the presence of
low agonist concentration (1 μM ACh) in the pipette solution showed
the characteristic sparse AChR channel openings, occasionally inter-
rupted by brief closures (Fig. 3). The distribution of single-channel open-
ings and burst durations ﬁttedwell with a single exponential component
in both cases. Table 1 shows the kinetic parameters obtained. In most of
the recordings, the distribution of the closed-time duration was de-
scribed by two components. The longest component was variable and
depended on the number of AChR channels in the patch, as described
by Sine and Steinbach [40]. The briefest component was minor and as
previously reported very likely corresponds to the reopening of the
closed channel [40].
When a 30 min pre-incubation with 60 μM cis-18:1ω-9 was per-
formed before patch channel recordings with AChR (1 μM) in the
pipette, statistically signiﬁcant differences between the channel
open-state duration of control and FFA-exposed channels were foundcid 
11) 
octadecanoic acid 
(cis-18:1ω13)
elaidic acid 
(trans-18:1 ω9)
on of the cis double bond and the arrow indicates the position of the trans double bond.
Fig. 3. Single-channel patch-clamp recordings of ACh-activated channels in CHO-K1-A5 cells. Open time histograms (left) resulting from the analysis of the single-channel record-
ings and raw traces of single-channel currents (right) obtained in the cell-attached conﬁguration from CHO-K1/A5 cells expressing adult AChR activated by ACh (1 μM) in the ab-
sence or the presence of the indicated FFA (60 μM). Membrane potential: -70 mV.
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obtained in the presence of 60 μM cis-18:1ω-6. However, no changes
were observed in the channel mean open duration when incubations
were performed in the presence of 60 μM of FFAs with the double
bond at deeper positions inside the bilayer (cis-18:1ω-11 or cis-18:1
ω13), or with 60 μM of trans-18:1ω-9. Compared to the control condi-
tion, closed-time distributions showed no modiﬁcations in either the
duration or the area of the briefer component of the closed time histo-
gram in the presence of any of the FFAs tested. Furthermore, the chan-
nel amplitude was not signiﬁcantly modiﬁed by exposure to FFAs.
Burst-time histograms were composed in all cases of one component
similar in duration to the open-time component, probably reﬂecting
single apertures. Thus, when cells were pre-incubated with either
60 μM cis-18:1ω-9 or cis-18:1ω-6, a statistically signiﬁcant decrease
of this component was evidenced in accordance with the diminution
of the mean open time, thus conﬁrming AChR current inhibition by
these two FFAs.Table 1
AChR channel properties in the presence of a ﬁxed concentration of FFAs (60 μM). Currents
from CHO-K1/A5 cells expressing adult AChR. Each data corresponds to the average±S.D. v
Amplitude
(pA)
τopen (ms) τbu
Control 5.31±0.64 0.85±0.09 0.9
cis-18:1ω-6 5.27±0.39 0.60±0.06a 0.6
cis-18:1ω-9 5.49±0.23 0.60±0.08a 0.7
trans-18:1ω-9 5.20±0.44 0.80±0.08 0.8
cis-18:1ω-11 4.70±0.35 0.80±0.12 0.9
cis-18:1ω-13 5.34±0.45 0.89±0.03 1.0
a Statistically signiﬁcant differences with respect to the control condition (pb0.003).3.3. Biophysical properties of AChR-rich membranes treated with FFAs
Considering that only two of the ﬁve FFAs tested (the ones with
the double bond at a more superﬁcial position inside the membrane)
modiﬁed AChR function, we next studied the biophysical properties
of AChR-rich membranes in the presence of different FFAs.
Owing to the effect of dipolar relaxation processes, Laurdan has
the physical capacity to sense the molecular dynamics and polarity
in its environment [31,32]. The principal dipoles sensed by Laurdan
in the membrane are water molecules [41]. The extent of their pene-
tration in the local membrane packing gives a measure of the phos-
pholipid order. GP values calculated from Laurdan spectra therefore
provide information on the ﬂuidity of the membrane [41,42]. We
found a direct correlation between FFA structure and membrane per-
turbations. Fig. 4a shows that once incorporated into the membrane,
the trans-unsaturated FFAs induced a slight and saturable decrease
in the GP values, resulting in a curve similar to that of the control,were measured following the patch-clamp technique in the cell-attached conﬁguration
alues.
rst (ms) τclosed (briefest component) n
(ms) (area)
9±0.14 0.14±0.07 0.051±0.016 10
7±0.03a 0.14±0.02 0.063±0.040 5
2±0.08a 0.07±0.01 0.074±0.032 4
9± 0.10 0.09±0.03 0.040±0.020 6
4±0.14 0.10±0.02 0.036±0.019 6
7±0.06 0.13±0.04 0.060±0.021 5
ab
Fig. 4. Laurdan excitation GP (a) and anisotropy of the ﬂuorescence probe DPH (b), in
the presence of increasing concentrations of cis-18:1ω-6 (○), cis-18:1ω-9 (□), cis-
18:1ω-11 (♦), cis-18:1ω-13 (▾) and trans-18:1ω-9 (■), or only vehicle (control condi-
tion, ●). Each point corresponds to the average±S.D. of more than four independent
experiments. Statistically signiﬁcant differences (pb0.01) were found in all the exper-
imental conditions when compared with the initial condition.
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Fig. 5. Titration of AChR-rich membranes with CrV. Membranes were previously incu-
bated for 45 min with increasing concentrations of a) cis-18:1ω-6 and b) cis-18:1ω-9
(control, ; 10 μM,●; 20 μM, ♦; 40 μM,▾; 60 μM, ▲; 80 μM■), in the absence or pres-
ence of 1 mM Carb (closed and open symbols, respectively).
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hand, all the cis-monounsaturated FFAs tested caused membrane
order perturbations dependent on the position of the double bond
(Fig. 4a), with cis-18:1ω-9 (oleic acid) increasing membrane ﬂuidity
the most. Because Laurdan is superﬁcially located in the membrane,
it was expected that cis-18:1ω-6 would be the FFA having the
greatest effect on the membrane. However, this FFA, together with
cis-18:1ω-13, perturbed GP values the least. cis-18:1ω-11 had an in-
termediate effect.
It is also possible that on account of Laurdan's shallow location in
the membrane bilayer, the probe is not able to sense the actual mag-
nitude of the perturbation caused by FFAs with their double bond in
position 11 or 13. We therefore resorted to the ﬂuorescence probe
DPH that localizes deeply in the hydrophobic core of the lipid bilayer
[43]. DPH has most frequently been used for studies on the structure
and dynamic properties of membranes and to assess membrane ﬂuid-
ity and/or order [44–49]. Analogous studies were performed measur-
ing its anisotropy. As in the case of the results obtained with Laurdan,
DPH anisotropy decreased most with cis-18:1ω-9, followed by cis-
18:1ω-11. trans-18:1ω-9 induced small and constant diminutions in
DPH anisotropy (Fig. 4b). When the membranes were treated with
cis-18:1ω-6 the DPH anisotropy perturbations differed from those in
the GP studies, probably because the DPH was too distant from the
double bond of cis-18:1ω-6 to sense its effect in the neighboring
lipids. As DPH is deep inside the membrane the largest anisotropy
decrease was expected to occur with FFAs having their double bond
in the position furthest along the acyl chain (cis-18:1ω-13), but in
fact the measured anisotropy values were similar to those measured
with cis-18:1ω-6. Taking together GP and anisotropy membrane per-
turbations by these cis-monounsaturated FFAs, it is clear that the lat-
ter modify membrane order to a greater or lesser degree, dependingon the location of the double bond, the highest effect being observed
when the double bond is near the middle of the acyl chain. In con-
trast, trans-unsaturated FFAs had next to no effect.3.4. FFAs induce AChR conformational changes
The AChR is an allosteric protein, which has two closed stable
states: one in the absence of agonist (R) and the other induced by a
prolonged exposure to agonists (D). Both R and D states are charac-
terized by a distinct protein conformation [9]. In previous studies
we used the value of the dissociation constant (KD) of the AChR ion-
channel blocker CrV to infer the conformational state of the AChR
[14] based on the fact that CrV displays higher afﬁnity for the D
state of the AChR than for its R state [50]. We also demonstrated
that both steroids and certain FFAs induced perturbations of the
AChR conformational states [14]. Here, we studied the effect pro-
duced by monounsaturated FFAs on the conformational state of the
AChR, using T. californica AChR-rich membranes with the AChR either
in the R or in the D state. AChR-rich membranes were ﬁrst incubated
with different concentrations of FFAs (up to 80 μM) and then titrated
with CrV. Fig. 5 shows the curves obtained with the normalized CrV
ﬂuorescence emission as a function of the molar concentration of
CrV for the AChR in the R and D states, respectively. The latter is dis-
placed to the left because of the higher afﬁnity of CrV for the D state.
When the membranes were previously exposed to FFAs, the experi-
mental curves were qualitatively different for almost all the FFAs test-
ed. In the presence of cis-18:1ω-6, the curves obtained in the absence
of agonist were quite similar to the control one, whereas in the pres-
ence of agonist the curves were displaced to the right, in a FFA
concentration-dependent manner, approaching the control curve in
the R state (Fig. 5a). When the FFA added was cis-18:1ω-9, the curves
obtained in the absence of agonist were displaced to the left, towards
those obtained with the AChR in the D state, and in the presence of
agonist they were displaced to the right, towards those obtained
with the AChR in the R state: in both cases, higher FFA concentrations
made for larger displacements (Fig. 5b). Fig. 6 shows the KD values
obtained with membranes treated with different monounsaturated-
FFAs in the presence or absence of Carb. All unsaturated FFAs in-
creased KD values when the membranes were incubated in the pres-
ence of agonist (D state in the control condition).
To obtain complementary evidence on AChR conformational
changes caused by FFAs, we performed quenching experiments with
AChR puriﬁed from T. californica membranes labeled with a ﬂuores-
cent lipophilic probe (pyrene-maleimide) speciﬁc for sulfhydryl
groups in a hydrophobic environment following the protocol used
by Narayanaswami et al. [28]. The pyrene attached to the AChR was
located in a shallow position, close to the membrane-water interface
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Fig. 6. Changes in KD values of CrV by the addition of FFA. KD values of CrV, calculated from the titration curves, as a function of increasing concentrations of a) cis-18:1ω-6 (●),
b) cis-18:1ω-9 (■), c) cis-18:1ω-11 (♦), d) cis-18:1ω-13 (▾) and e) trans-18:1ω-9 (▲), in the absence and presence of 1 mM Carb (closed and open symbols, respectively).
Each point corresponds to the average±S.D. of more than four independent experiments. Statistically signiﬁcant differences (*, pb0.05 and **, pb0.01) compared with the control
values (absence of FFAs).
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carbon 5 (5-SLFA) was added to membranes previously treated with
different FFAs. The quenching proﬁle of the pyrene ﬂuorescence in
each case and the calculated Stern–Volmer quenching constants
(KSV) are shown in Figs. 7a and b, respectively. When the membrane
was pre-incubated with cis-monounsaturated FFAs the quenching of
pyrene diminished, as reﬂected in a decrease in KSV values; cis-18:1
ω-6 exerted the lowest effect and the trans-monounsaturated FFA
had no effect. Thus, the presence of cis-monounsaturated FFAs in
the membrane caused a rearrangement of the pyrene position inside
the membrane, implying a local topological change in the AChR γTM
segment.a b
Fig. 7. Fluorescence quenching with a spin-label FFA. a) Plots of F/Fo ofmembranes previ-
ously treated with only vehicle (control condition, ●) or with 60 μM of cis-18:1ω-6 (○),
cis-18:1ω-9 (□), cis-18:1ω-11 (♦), cis-18:1ω-13 (▾) and trans-18:1ω-9 (■) followed by
incubation with increasing amounts of 5-SLFA. b) Stern–Volmer constants (Ksv) obtained
from Stern–Volmer plots (Fo/F) of the data of (a). Filled and open bars correspond to Ksv
obtained from samples treated with the vehicle for the 5-SLFA (ethanol) or with 5-SLFA,
respectively. Each point/bar corresponds to the average±S.D. of more than four indepen-
dent experiments. Statistically signiﬁcant differences (*, pb0.05 and **, pb0.01) compared
with the control values (i.e. in the absence of FFAs).4. Discussion
In the present study we focused on the mechanism of FFA inhibi-
tion of AChR function. Previous studies have shown that highly hydro-
phobicmolecules such as FFAs and steroids can act as NCA of the AChR
[16,51–53]. It has been proposed that FFAs may act on AChR through
the protein–lipid interface, by previously partitioning inside themem-
brane [13,14,39,53]. Using the patch-clamp technique we have shown
that irrespective of their chemical structure, four different FFAs (the
unsaturated FFAs arachidonic and docosahexanoic acid and the satu-
rated FFAs palmitic and nonadecanoic acid) inhibit AChR function.
However, their mechanism of action is still not fully understood.
To learn more about the way in which FFAs affect AChR function, in
the present studywe focused on FFAswith a single double bond located
at different positions along an 18-carbon acyl chain: petroselenic acid
(cis-18:1ω-6), oleic acid (cis-18:1ω-9), vaccenic acid (cis-18:1ω-11),
cis-13-octadecenoic acid (cis-18:1ω-13) and elaidic acid (trans-18:1ω-
9). We used different experimental approaches to identify the main
properties conditioning AChR function at the lipid–protein interface.
Table 2 summarizes the results as a function of the position of the dou-
ble bond of the FFA used.
Trp and Laurdan constitute a good donor–acceptor pair for FRET
measurements, with a minimum donor–acceptor distance of 14 Å
which roughly corresponds to the diameter of the ﬁrst shell of lipids
surrounding the AChR TM region [37]. Whatever moves Laurdan mol-
ecules away from the AChR environment will decrease FRET efﬁciency,
as is the case with exogenous hydrophobic molecules [37]. However,
depending on the location of these exogenous compounds at the
lipid-AChR interface, i.e. annular and/or non-annular sites, the proﬁle
of the diminution varies. All the FFAs studied partitioned at the lipid-
AChRmicroenvironment; all, except cis-18:1ω-6, located at both annu-
lar and non-annular sites (Fig. 2). It is noteworthy that only cis-18:1ω-6,
whose double bond is located more superﬁcially inside the membrane,
was restricted to annular sites.
Once conﬁrmed that all FFAs partitioned at the lipid-AChR inter-
face, functional studies were performed using the patch-clamp
Table 2
Summary of the experimental data obtained with different FFAs.
cis-18:1ω6 cis-18:1ω9 cis-18:1ω11 cis-18:1ω13 trans-18:1ω9
Sites at lipid-AChR interface Aa A+NAb A+NA A+NA A+NA
AChR function inhibition + ++ – – –
GP modiﬁcation ++ +++ ++ + –
Anisotropy modiﬁcation + +++ ++ ++ –
R-state perturbation – ++ ++ ++ –
M4 perturbation + ++ ++ ++ –
D-state perturbation ++ ++ + + +
aA: annular sites, bNA: non-annular sites.
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muscle type AChR in the same manner: only cis-18:1ω-6 and cis-
18:1ω-9 could alter single channel currents. The net effect of these
two FFAs was a diminution in both the mean open time duration
and the mean burst duration (Table 1). The latter modiﬁcation is in
agreement with a shortening of the main open component duration,
reﬂecting, as previously stated, single apertures. The site of action of
these two FFAs seems to be distant from the channel pore since no
ﬂickering behavior was observed in the single-channel recordings.
Moreover, since none of the other kinetic parameters were modiﬁed
after pre-incubationwith both FFAs, we can infer that the receptor un-
dergoes a transition from the inhibited state to its closed conforma-
tion. The other two monounsaturated FFAs tested, cis-18:1ω-11 and
cis-18:1ω-13, exerted no effect on AChR function. The key difference
between the different FFAs studied here resides in the double bond:
cis-18:1ω-6 and cis-18:1ω-9, which effectively behaved as AChR in-
hibitors, have the double bond at a more superﬁcial location, whereas
cis-18:1ω-11 and cis-18:1ω-13, the two cis-FFAswith no inhibitory ef-
fect, have the double bond more deeply inside the membrane. Inter-
estingly, trans-18:1ω-9, with the double bond at the same position
as cis-18:1ω-9 but with an isomerismwhich leads to a different spatial
arrangement, did not modify channel kinetics. Previous studies also
demonstrated that other FFAs with different chemical structures
(18:0, 20:0, 18:2, 18:3, 20:4 and 22:6) localize at annular and non-
annular sites [14,19], and that 20:0, 20:4 and 22:6 act as AChR inhibi-
tors [54]. Taking together the fact that not all FFAs inhibit AChR func-
tion and that all FFAs localize at the lipid-AChR interface but not all at
the same boundary sites, the location in non-annular sites may not be
a prerequisite for AChR inhibition.
To determine whether inhibition of AChR function –or the lack of
it– by certain FFAs can be explained by the biophysical characteristics
of the AChR-lipid environment, we studied the effect of each FFA on
the biophysical properties of AChR-richmembranes. GP of the ﬂuores-
cence probe Laurdan and anisotropy experiments with DPH shows
that all cis-monounsaturated FFAs modify membrane order, albeit to
different extents, depending on their chemical structure. Oleic acid
(cis-18:1ω-9) affects this property more than all other FFAs, a pertur-
bation that can be related to the fact that this FFA exerts the strongest
inhibitory effect on the AChR. Petroselenic acid (cis-18:1ω-6) has the
same effect as that of vaccenic acid (cis-18:1ω-11) according to GP
and to cis-13-octadecenoic acid (cis-18:1ω-13) anisotropy studies.
Since these latter two FFAs did not inhibit the AChR but did modify
the membrane order in the samemanner as cis-18:1ω-6, we conclude
that changes in membrane ﬂuidity as a consequence of the addition of
FFAs are not per se responsible for AChR inhibition.
Complementary studies of AChR conformational changes in the
presence of FFAs were performed with the ﬂuorescence dye CrV
which displays different afﬁnities for the R and D states of the AChR.
Desensitizing concentration of agonist decreased the KD for CrV, indi-
cating that AChR undergoes conformational changes leading to the
high-afﬁnity D state [55]. When AChR-rich membranes in the R-state
were incubated with the cis-monounsaturated FFAs, all except cis-
18:1 ω-6 decreased KD to values approaching those observed for the
agonist-induced D state. This result indicates that certain FFAs inducea conformational change in the AChR, suggesting a direct correlation
between localization at non-annular sites and perturbation of the
AChR R-state. However, these conformational changes do not sufﬁce
to account for the inhibitory effect of FFAs on AChR, since in the R-
state cis-18:1ω-9 produced a conformational change whereas cis-
18:1ω-6 did not. trans-18:1ω-9 caused no modiﬁcation of KD values
although it localizes at both annular and non-annular sites, suggesting
that it is the kink of the double bond that is responsible for AChR R-
state perturbations.When similar studies were performed in the pres-
ence of agonist, all monounsaturated FFAs modiﬁed the D state of
AChR by increasing the KD values. However, a marked differentiation
in the proﬁle of variation between cis-18:1ω-6 and ω-9 on the one
hand and the rest of the FFAs on the other, can be appreciated. Higher
perturbations of the AChR D-state, which can be related to cis-
monounsaturated FFAs with the double bond at positions relatively
superﬁcial at the lipid–protein interface, independently of the sites
they occupy, can be correlated with AChR-inhibition.
An additional experiment focusing on AChR conformation was car-
ried out: the topological position of the M4 TM segments, which has
extensive contact with the lipid bilayer [3], was then evaluated in
the presence of the monounsaturated FFAs. Although M4 is relatively
far from both the channel lumen and the transmitter binding sites,
functional analyses have shown that mutations of some of the resi-
dues in the M4 segment of different AChR subunits alter the gating
equilibrium constant [56–60]. These and other results suggest that
M4 residues experience a synchronous motion during the gating
reaction [55–59]. Fluorescence quenching experiments with puriﬁed
AChR from Torpedo membrane labeled with N-PyrM in the presence
of FFAs showed that the presence of all cis-monounsaturated FFAs
led to a conformational change in the TM portion of the AChR. Two
groups of compounds can be proposed based on the different statisti-
cal signiﬁcance level of cis-18:1ω-6 (pb0.05) compared with the rest
of the cis-unsaturated FFAs (pb0.01). These can be related to different
site locations at the lipid-AChR interface: higher signiﬁcance levels
could correspond to M4 topological perturbations at both annular
and non-annular sites, whereas lower M4 topological perturbations
could indicate the presence of FFAs only at annular sites. The fact
that the presence of trans-18:1ω-9 inside themembrane did notmod-
ify Ksv even though it localizes at both annular and non-annular sites
further supports this interpretation: the kink of the double bond
may be responsible for the occurrence of M4 topological perturba-
tions, whereas their magnitude is likely related to the localization of
the FFAs. As stated above, AChR conformational perturbations as a
consequence of localization at different sites are not sufﬁcient to
fully explain the inhibitory effect of FFAs on AChR function.
Clearly, FFAs exert different effects on the AChR conformational
state depending on their structural characteristics: the presence, po-
sition and isomerism of the double bond seem to play an important
role in the modiﬁcation of the conformational state of the AChR
both in its R and D states. There is a correlation between the localiza-
tion of certain molecules at non-annular sites and perturbation of the
AChR R state without necessarily affecting AChR function, whereas
perturbations of the AChR D-state by the presence of molecules at an-
nular and/or non-annular sites can be related to the AChR inhibition
2519V.L. Perillo et al. / Biochimica et Biophysica Acta 1818 (2012) 2511–2520function. Taken together, these data lead us to conclude that the po-
sition of the torsion angle of unsaturated FFAs is a key factor in chan-
nel blockage.
The sequence of structural events coupling ligand binding with
channel gating is considered a conserved core mechanism: it is postu-
lated to begin with movements at the ligand-binding loops, followed
by the displacement of loops located at the interface between the
extracellular ligand binding domain and the TM domain, continuing
with the tilting/bending of the pore-lining M2 helix, and ending with
movements of M4, M3 and M1 helices in the TM domain [61,62]. FFAs
exert their action by an allosteric mechanism at the lipid-AChR inter-
face: all FFAs effectively localize in the environment of the protein, not
all at the same sites, and they are all detected by the AChR as indicated
by the changes in the topology of the M4 segment in their presence.
However, only those FFAs having the double bond at a superﬁcial posi-
tion relative to the lipid bilayer were found to act as AChR inhibitors.
This suggests that those FFAs with the double bond at a superﬁcial po-
sition inside the membrane are probably at the level of the conserved
core structure for AChR gating and hence could perturb this synchro-
nous mechanism.
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